Previous Close | 8.00 |
Open | 9.00 |
Bid | 12.30 |
Ask | 13.00 |
Strike | 18.00 |
Expire Date | 2022-07-15 |
Day's Range | 8.00 - 9.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
CAMP HILL, Pa., June 28, 2022--Rite Aid Corporation (NYSE: RAD) ("Rite Aid" or the "Company") announced today the early tender results of its previously announced series of tender offers (the "Tender Offers") to purchase for cash certain of its outstanding series of senior notes listed in the table below (collectively, the "Notes") for an aggregate purchase price, excluding accrued and unpaid interest, of up to $150,000,000 (the "Maximum Aggregate Cap"). The Tender Offers are being made pursuant
Rite Aid CEO Heyward Donigan joins Yahoo Finance to discuss the Supreme Court ruling on abortion as an employer, health care, and the pharmacy business.
Rite Aid's (RAD) Q1 results gain from higher sales of non-COVID-19 prescriptions and continued momentum at Elixir. Management raises its revenue guidance for fiscal 2023.